Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Evolent Health's EV/EBITDA was 16.5× on Jan 30, 2026, against 22.5× a year earlier. Over the last 5 years it ranged from 16.5× to 149.8×, with a median of 52.1×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 16.5× | −1.1 |
| 2025 | Dec 31, 2025 | 17.6× | −6.1 |
| 2024 | Dec 31, 2024 | 23.7× | −40.6 |
| 2023 | Dec 29, 2023 | 64.3× | +13.4 |
| 2022 | Dec 30, 2022 | 50.9× | −17.9 |
| 2021 | Dec 31, 2021 | 68.8× | – |
See a number that looks wrong?